Clinical Trials Browser

Not yet recruiting × envafolimab × Other solid neoplasm × Clear all

NCT07327411 2026-01-08

Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors

Phase 2 Not yet recruiting

Other solid neoplasm

Advanced Refractory Solid Tumors

NCT05645094 2022-12-13

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Not yet recruiting

GastrointestinalOther solid neoplasm

Locally Advanced Rectal Carcinoma